advertisement
Aihara M 23
Showing records 1 to 23 | Display all abstracts from Aihara M82690 Reoperation rates after Ex-PRESS versus trabeculectomy for primary open-angle or normal-tension glaucoma: a national database study in Japan
Hashimoto Y
Eye 2019; 0:
82126 Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma
Aihara M
Japanese Journal of Ophthalmology 2019; 63: 402-409
82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Uchida T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82126 Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma
Kuwayama Y
Japanese Journal of Ophthalmology 2019; 63: 402-409
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Lu F
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82690 Reoperation rates after Ex-PRESS versus trabeculectomy for primary open-angle or normal-tension glaucoma: a national database study in Japan
Michihata N
Eye 2019; 0:
82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Ueta T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Kawata H
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Honjo M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541
82126 Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma
Miyata K
Japanese Journal of Ophthalmology 2019; 63: 402-409
82690 Reoperation rates after Ex-PRESS versus trabeculectomy for primary open-angle or normal-tension glaucoma: a national database study in Japan
Matsui H
Eye 2019; 0:
82126 Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma
Ohtani S
Japanese Journal of Ophthalmology 2019; 63: 402-409
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Tanaka Y
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541
82690 Reoperation rates after Ex-PRESS versus trabeculectomy for primary open-angle or normal-tension glaucoma: a national database study in Japan
Fushimi K; Yasunaga H
Eye 2019; 0:
82126 Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma
Ideta R
Japanese Journal of Ophthalmology 2019; 63: 402-409
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Yamamura K
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82690 Reoperation rates after Ex-PRESS versus trabeculectomy for primary open-angle or normal-tension glaucoma: a national database study in Japan
Aihara M
Eye 2019; 0:
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Odani-Kawabata N
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82126 Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma
Hashimoto Y; Sasaki N
Japanese Journal of Ophthalmology 2019; 63: 402-409
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Shams NK
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82126 Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma
Shirato S
Japanese Journal of Ophthalmology 2019; 63: 402-409
